|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.81 USD | -0.12% |
|
-4.41% | -11.12% |
| Market Cap | 3.23B 2.82B 2.59B 2.42B 4.59B 307B 4.66B 31.14B 12.1B 151B 12.12B 11.86B 521B | P/E 2026 * |
238x | P/E 2027 * | 25.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2.96B 2.59B 2.38B 2.22B 4.21B 282B 4.27B 28.59B 11.11B 139B 11.13B 10.89B 478B | EV / Sales 2026 * |
5.96x | EV / Sales 2027 * | 4.1x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | -0.12% | ||
| 1 week | -4.41% | ||
| Current month | -1.56% | ||
| 1 month | +20.89% | ||
| 3 months | +9.23% | ||
| 6 months | -11.00% | ||
| Current year | -11.12% |
| 1 week | 25.53 |  | 27.2 |
| 1 month | 21 | | 28.38 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.06 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 2017-03-31 |
| Corporate Officer/Principal | 71 | 2025-12-02 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 2019-11-30 |
Todd Watanabe
BRD | Director/Board Member | 58 | 2015-12-31 |
Howard Welgus
BRD | Director/Board Member | 74 | 2020-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Sell | Director | -635 | 0.0005% | ||
| 06-14 | Sell | Director | -4,946 | 0.0040% | ||
| 06-04 | Free | Director | 22,445 | 0.0179% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | -4.41% | +86.76% | +194.97% | 3.23B | |
| +4.73% | +3.38% | +19.53% | -8.89% | 66.56B | |
| -1.93% | +0.39% | +58.62% | +226.33% | 56.51B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.98B | |
| +3.45% | +6.04% | -49.46% | -55.91% | 40.46B | |
| +3.04% | +0.04% | +62.66% | -24.29% | 31.91B | |
| +10.01% | +18.57% | +161.59% | -34.48% | 31.65B | |
| +2.68% | +2.73% | +70.72% | +88.24% | 23.35B | |
| +2.87% | +16.83% | +3.78% | +192.67% | 19.46B | |
| -0.13% | +2.75% | +67.48% | +130.07% | 17.18B | |
| Average | +2.57% | +7.55% | +52.38% | +75.08% | 33.33B | |
| Weighted average by Cap. | +2.76% | +7.21% | +44.10% | +55.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 497M 435M 399M 372M 706M 47.33B 717M 4.79B 1.86B 23.27B 1.87B 1.83B 80.17B | 646M 565M 519M 484M 917M 61.49B 931M 6.23B 2.42B 30.23B 2.42B 2.37B 104B |
| Net income | 15.18M 13.27M 12.19M 11.36M 21.56M 1.44B 21.88M 146M 56.9M 710M 56.97M 55.74M 2.45B | 134M 117M 108M 101M 191M 12.78B 194M 1.29B 503M 6.28B 504M 493M 21.65B |
| Net Debt | -265M -231M -213M -198M -376M -25.19B -381M -2.55B -992M -12.38B -993M -972M -42.67B | -580M -507M -466M -434M -824M -55.21B -836M -5.59B -2.17B -27.14B -2.18B -2.13B -93.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$25.81 | -0.12% | 1,198,181 |
| 26-07-01 | US$25.84 | -1.45% | 937,771 |
| 26-06-30 | US$26.22 | -2.02% | 1,354,101 |
| 26-06-29 | US$26.76 | -0.89% | 1,386,238 |
| 26-06-26 | US$27.00 | +1.16% | 3,711,679 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
